Latest Breaking News On - Molecular therapy nucleic acids - Page 1 : comparemela.com

Sweet move: a modified sugar enhances antisense oligonucleotide safety and efficacy

Sweet move: a modified sugar enhances antisense oligonucleotide safety and efficacy
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Takanori yokotaTaiki matsubayashiOsaka universityMolecular therapy nucleic acidsTokyo medicalDental university

New chemical modification improves effectiveness and safety of ASO therapy for CNS diseases

Diseases that affect the brain and spinal cord can be particularly devastating, and finding new and more effective ways to treat these conditions is an important goal for researchers and clinicians alike.

Takanori yokotaTaiki matsubayashiOsaka universityMolecular therapy nucleic acidsTokyo medicalDental university

Sweet move: A modified sugar enhances antisense oligonucleotide safety and efficacy for treating CNS disease

Researchers have found that a newly developed modified sugar increases the efficacy and safety of antisense oligonucleotides designed to treat central nervous system disease.

Taiki matsubayashiTakanori yokotaDepartment of neurologyOsaka universityNeurological scienceMolecular therapy nucleic acidsTokyo medicalDental universityMolecular therapy

Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook

Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofMont saint guibertWaals gewestMichel lussierDavid georgesExchange commissionIntellectual propertyChief executive officerCelyad oncologyMolecular therapy nucleic acidsMol ther nucleicPrivate securities litigation reform actAnnual reportOncology contactsMedia contact

Eleven Therapeutics Welcomes Dr Paloma H Giangrande as Chief Technology Officer

/PRNewswire/ Eleven Therapeutics, a pioneering biotechnology company specializing in next-generation mRNA therapeutics, proudly announces the appointment of.

United statesUnited kingdomPalomah giangrandeYaniv erlichWave life sciencesVp research operationsMelinda gates foundationUniversity of iowaEleven therapeuticsChief technology officerRare diseasesMolecular therapy nucleic acidsEleven therapeuticPaloma giangrandeTel avivMelinda gates